Gene transfer in purified human hematopoietic peripheral-blood stem cells by means of electroporation without prestimulation

Journal of Laboratory and Clinical Medicine

Volumn 141, Issue 2, 2003, Pages 138-149

  Weissinger, Florian ^a,b   Reimer, Peter ^a   Waessa, Tanja ^a   Buchhofer, Stefan ^a   Schertlin, Tobias ^a   Kunzmann, Volker ^a   Wilhelm, Martin ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; FAS ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; MONOCLONAL ANTIBODY; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; BIOSAFETY; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; ELECTROPORATION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; MUTAGENESIS; PERIPHERAL BLOOD STEM CELL; RETROVIRUS; UPREGULATION; VIRUS RECOMBINATION;

EID: 0037320203     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2003.14     Document Type: Article

References (24)

1. Hodgson CP, Xu G, Solaiman F, Zink MA. Biosynthetic retrovectoring systems for gene therapy. J Mol Med 1997;75:249-58.
2. Uchida N, He D, Friera AM, Reitsma M, Sasaki D, Chen B, et al. The unexpected G0/G1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood. Blood 1997;89:465-72.
3. Chu P, Lutzko C, Stewart AK, Dube ID. Retrovirus-mediated gene transfer into human hematopoietic stem cells. J Mol Med 1998;76:184-92.
4. Donahue RE, Kessler SW, Bodine D, McDonagh K, Dunbar C, Goodman S, et al. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 1992;176:1125-35.
5. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996;272:263-7.
6. Miyoshi H, Smith KA, Mosier DE, Verma IM, Torbett BE. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 1999;283:682-6.
7. Case SS, Price MA, Jordan CT, Yu XJ, Wang L, Bauer G, et al. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci U S A 1999;96:2988-93.
8. Evans JT, Kelly PF, O'Neill E, Garcia JV. Human cord blood CD34+CD38- cell transduction via lentivirus-based gene transfer vectors. Hum Gene Ther 1999;10:1479-89.
9. Floch V, Le Bolc'h G, Audrezet MP, Yaouanc JJ, Clement JC, des Abbayes H, et al. Cationic phosphonolipids as non viral vectors for DNA transfection in hematopoietic cell lines and CD34+ cells. Blood Cell Mol Dis 1997;23:69-87.
10. Takahashi M, Furukawa T, Saitoh H, Aoki A, Koike T, Moriyama Y, et al. Gene transfer into human leukemia cell lines by electroporation: experience with exponentially decaying and square wave pulse. Leuk Res 1991;15:507-13.
11. Pahl HL, Burn TC, Tenen DG. Optimization of transient transfection into human myeloid cell lines using a luciferase reporter gene. Exp Hematol 1991;19:1038-41.
12. Toneguzzo F, Keating A. Stable expression of selectable genes introduced into human hematopoietic stem cells by electric field-mediated DNA transfer. Proc Natl Acad Sci U S A 1986;83:3496-9.
13. Li LH, McCarthy P, Hui SW. High-efficiency electrotransfection of human primary hematopoietic stem cells. Faseb J 2001;15:586-8.
14. Wu MH, Liebowitz DN, Smith SL, Williams SF, Dolan ME. Efficient expression of foreign genes in human CD34(+) hematopoietic precursor cells using electroporation. Gene Ther 2001;8:384-90.
15. Hatzfeld A, Batard P, Panterne B, Taieb F, Hatzfeld J. Increased stable retroviral gene transfer in early hematopoietic progenitors released from quiescence. Hum Gene Ther 1996;7:207-13.
16. Smith KT, Shepherd AJ, Boyd JE, Lees GM. Gene delivery systems for use in gene therapy: an overview of quality assurance and safety issues. Gene Ther 1996;3:190-200.
17. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990;10:4239-42.
18. Nolta JA, Smogorzewska EM, Kohn DB. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 1995;86:101-10.
19. Yonemura Y, Ku H, Lyman SD, Ogawa M. In vitro expansion of hematopoietic progenitors and maintenance of stem cells: comparison between FLT3/FLK-2 ligand and KIT ligand. Blood 1997;89:1915-21.
20. Tisdale JF, Hanazono Y, Sellers SE, Agricola BA, Metzger ME, Donahue RE, et al. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 1998;92:1131-41.
21. Larochelle A, Vormoor J, Hanenberg H, Wang JC, Bhatia M, Lapidot T, et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med 1996;2:1329-37.
22. Williams DA. Ex vivo expansion of hematopoietic stem and progenitor cells: -robbing Peter to pay Paul? Blood 1993;81:3169-72.
23. Li LH, Sen A, Murphy SP, Jahreis GP, Fuji H, Hui SW. Apoptosis induced by DNA uptake limits transfection efficiency. Exp Cell Res 1999;253:541-50.
24. Harrison GS, Wang Y, Tomczak J, Hogan C, Shpall EJ, Curiel TJ, et al. Optimization of gene transfer using cationic lipids in cell lines and primary human CD4+ and CD34+ hematopoietic cells. Biotechniques 1995;19:816-23.